Cargando…

Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)

Detalles Bibliográficos
Autores principales: Phillips, Adrienne, Fields, Paul, Hermine, Olivier, Taylor, Graham P, Delioukina, Maria, Horwitz, Steven, Ramos, Juan C, Meniane, Jean-Côme, Barta, Stefan K, Brites, Carlos, Pereria, Juliana, Beltran, Brady, Casanova, Luis, Wandroo, Farooq, Feldman, Tatyana, Dwyer, Karen, Kurman, Michael, Conlon, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578121/
http://dx.doi.org/10.1186/1742-4690-12-S1-P31
_version_ 1782391067678605312
author Phillips, Adrienne
Fields, Paul
Hermine, Olivier
Taylor, Graham P
Delioukina, Maria
Horwitz, Steven
Ramos, Juan C
Meniane, Jean-Côme
Barta, Stefan K
Brites, Carlos
Pereria, Juliana
Beltran, Brady
Casanova, Luis
Wandroo, Farooq
Feldman, Tatyana
Dwyer, Karen
Kurman, Michael
Conlon, Kevin
author_facet Phillips, Adrienne
Fields, Paul
Hermine, Olivier
Taylor, Graham P
Delioukina, Maria
Horwitz, Steven
Ramos, Juan C
Meniane, Jean-Côme
Barta, Stefan K
Brites, Carlos
Pereria, Juliana
Beltran, Brady
Casanova, Luis
Wandroo, Farooq
Feldman, Tatyana
Dwyer, Karen
Kurman, Michael
Conlon, Kevin
author_sort Phillips, Adrienne
collection PubMed
description
format Online
Article
Text
id pubmed-4578121
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45781212015-09-23 Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL) Phillips, Adrienne Fields, Paul Hermine, Olivier Taylor, Graham P Delioukina, Maria Horwitz, Steven Ramos, Juan C Meniane, Jean-Côme Barta, Stefan K Brites, Carlos Pereria, Juliana Beltran, Brady Casanova, Luis Wandroo, Farooq Feldman, Tatyana Dwyer, Karen Kurman, Michael Conlon, Kevin Retrovirology Poster Presentation BioMed Central 2015-08-28 /pmc/articles/PMC4578121/ http://dx.doi.org/10.1186/1742-4690-12-S1-P31 Text en Copyright © 2015 Phillips et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Phillips, Adrienne
Fields, Paul
Hermine, Olivier
Taylor, Graham P
Delioukina, Maria
Horwitz, Steven
Ramos, Juan C
Meniane, Jean-Côme
Barta, Stefan K
Brites, Carlos
Pereria, Juliana
Beltran, Brady
Casanova, Luis
Wandroo, Farooq
Feldman, Tatyana
Dwyer, Karen
Kurman, Michael
Conlon, Kevin
Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)
title Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)
title_full Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)
title_fullStr Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)
title_full_unstemmed Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)
title_short Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)
title_sort anti-ccr4 monoclonal antibody kw-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult t-cell leukemia-lymphoma (atl)
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578121/
http://dx.doi.org/10.1186/1742-4690-12-S1-P31
work_keys_str_mv AT phillipsadrienne anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl
AT fieldspaul anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl
AT hermineolivier anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl
AT taylorgrahamp anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl
AT delioukinamaria anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl
AT horwitzsteven anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl
AT ramosjuanc anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl
AT menianejeancome anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl
AT bartastefank anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl
AT britescarlos anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl
AT pereriajuliana anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl
AT beltranbrady anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl
AT casanovaluis anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl
AT wandroofarooq anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl
AT feldmantatyana anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl
AT dwyerkaren anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl
AT kurmanmichael anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl
AT conlonkevin anticcr4monoclonalantibodykw0761mogamulizumaborinvestigatorschoiceinsubjectswithrelapsedorrefractoryadulttcellleukemialymphomaatl